Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 14, 2022 8-K
424B5 Sep 14, 2022 424B5
8-K Sep 14, 2022 8-K
10-Q Aug 11, 2022 10-Q
8-K Aug 11, 2022 8-K
4 May 12, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 12, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 12, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 12, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 12, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 12, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 12, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
8-K May 12, 2022 8-K
10-Q May 12, 2022 10-Q
8-K May 12, 2022 8-K
4 May 11, 2022
DEF 14A Apr 12, 2022 DEF 14A
8-K Apr 11, 2022 FORM 8-K
10-K Mar 25, 2022 10-K
8-K Mar 25, 2022 8-K
8-K Feb 28, 2022 8-K
SC 13G Feb 18, 2022
SC 13G/A Feb 15, 2022
8-K Feb 14, 2022 8-K
SC 13G/A Feb 14, 2022 LARIMAR THERAPEUTICS, INC.
← Newer Page 9 of 28 · 696 filings Older →